Tumour cell lysate-loaded dendritic cell vaccine induces biochemical and memory immune response in castration-resistant prostate cancer patients

BACKGROUND: Recently, we produced a tumour antigen-presenting cells (TAPCells) vaccine using a melanoma cell lysate, called TRIMEL, as an antigen source and an activation factor. Tumour antigen-presenting cells induced immunological responses and increased melanoma patient survival. Herein, we inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Reyes, D, Salazar, L, Espinoza, E, Pereda, C, Castellón, E, Valdevenito, R, Huidobro, C, Inés Becker, M, Lladser, A, López, M N, Salazar-Onfray, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777003/
https://www.ncbi.nlm.nih.gov/pubmed/23989944
http://dx.doi.org/10.1038/bjc.2013.494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777003/
https://www.ncbi.nlm.nih.gov/pubmed/23989944
http://dx.doi.org/10.1038/bjc.2013.494

Ejemplares similares